We are live on ! Find out more
MED icon

Medifast

246 hedge funds and large institutions have $1.52B invested in Medifast in 2019 Q1 according to their latest regulatory filings, with 42 funds opening new positions, 98 increasing their positions, 68 reducing their positions, and 40 closing their positions.

New
Increased
Maintained
Reduced
Closed

44% more repeat investments, than reductions

Existing positions increased: 98 | Existing positions reduced: 68

41% more call options, than puts

Call options by funds: $14.9M | Put options by funds: $10.5M

8% more capital invested

Capital invested by funds: $1.41B → $1.52B (+$112M)

6.03% more ownership

Funds ownership: 94.7%100.73% (+6%)

5% more first-time investments, than exits

New positions opened: 42 | Existing positions closed: 40

0% less funds holding

Funds holding: 247246 (-1)

Holders
246
Holders Change
-1
Holders Change %
-0.4%
% of All Funds
5.32%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.04%
New
42
Increased
98
Reduced
68
Closed
40
Calls
$14.9M
Puts
$10.5M
Net Calls
+$4.36M
Net Calls Change
+$3.64M

MED Hedge Fund Activity: Q1 2019 in Review

246 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Medifast (MED) for Q1 2019, worth a combined $1.52B — up 7.9% from $1.41B a quarter earlier.

Buyers outnumbered sellers: 42 funds opened new MED positions and 40 closed out — a net gain of 2 holders — while 98 added to existing stakes and 68 trimmed.

The largest buyer was Hoplite Capital Management, opening a new position worth an estimated $33.3M. The largest seller was Renaissance Technologies, cutting an estimated $17.7M.

  • 246 institutional investors held Medifast (MED) as of Q1 2019, down from 247 in Q4 2018.
  • Funds reported $1.52B of Medifast stock for Q1 2019, up 7.9% quarter-over-quarter.
  • 42 funds opened new Medifast positions in Q1 2019 and 40 closed out, a net change of +2 holders.
  • The largest Medifast buyer in Q1 2019 was Hoplite Capital Management, an estimated $33.3M added.
  • The largest Medifast seller in Q1 2019 was Renaissance Technologies, an estimated $17.7M sold.

Based on aggregated 13F filings for Q1 2019.